Capitolis Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-149,167
Closed -$14.4M 2
2022
Q3
$14.4M Hold
149,167
1.03% 31
2022
Q2
$16.2M Hold
149,167
0.85% 33
2022
Q1
$17.7M Sell
149,167
-493,028
-77% -$61.1M 0.89% 29
2021
Q4
$90.4M Buy
642,195
+49,215
+8% +$6.3M 0.54% 45
2021
Q3
$69.3M Sell
592,980
-56,781
-9% -$6.98M 0.63% 39
2021
Q2
$75.3M Buy
649,761
+621,921
+2,234% +$72.5M 0.89% 26
2021
Q1
$3.34M Hold
27,840
0.06% 200
2020
Q4
$3.05M Buy
+27,840
New +$3.03M 0.05% 260

Other funds holding ABT

Capitolis Advisors's ABT Position: Q4 2022 in Review

Capitolis Advisors sold out of Abbott (ABT) in Q4 2022, closing a stake of 149,167 shares — an estimated $14.4M sold.

Capitolis Advisors first reported a position in ABT in Q4 2020 and held it in 8 quarters. The position peaked at $90.4M in Q4 2021. 2,764 funds tracked by Wall St. Rank hold ABT as of Q4 2022.

  • Capitolis Advisors reported no remaining Abbott position as of Q4 2022 after selling out during the quarter.
  • Capitolis Advisors sold 149,167 Abbott shares in Q4 2022, an estimated $14.4M.
  • Capitolis Advisors first reported a position in Abbott in Q4 2020 and held it in 8 quarters.
  • Capitolis Advisors's Abbott position peaked at $90.4M in Q4 2021.
  • 2,764 funds tracked by Wall St. Rank held Abbott as of Q4 2022.

Based on Capitolis Advisors's 13F filing for Q4 2022.